WAYNE, N.J., July 6, 2012 /PRNewswire/ -- Maquet Critical Care AB and MAQUET Medical Systems USA today issued the following update regarding its voluntary worldwide field correction for its C20, C30 and C40 FLOW-i Anesthesia Systems. The recall was related to a software problem with the MAN/AUTO switch used for changing between manual and automatic ventilation modes. The corrective action associated with this field correction included upgrading the affected systems' software as well as providing new corresponding user's manuals. The U.S. Food and Drug Administration (FDA) has classified this as a Class I recall.
This action only affected FLOW-i Anesthesia Systems distributed between May 2010 and December 2011 and therefore, has no affect on the company's current product production, shipping or distribution processes.
In specific C20, C30 and C40 FLOW-i Anesthesia Systems, if the MAN/AUTO switch was not fully engaged in either an "ON" or "OFF position, but rather was placed in an "in- between position" for more than five seconds, a Technical Alarm TE 613 may have been generated. Activation of the Technical Alarm TE 613 causes the system to remain in the original mode selected and does not switch the ventilation mode. To deactivate the Technical Alarm TE 613, the system must be restarted.
In February 2012, MAQUET Medical Systems, USA and Maquet Critical Care AB initiated a voluntary field correction of FLOW-i Anesthesia System, model number C30, in the US. FLOW-i Anesthesia System model numbers C20, C30 and C40 were affected worldwide.
FDA defines Class I recalls as, "a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death."
For additional information regarding this closed field correction, please contact the local MAQUET Technical Support Department. For US Technical Support, call 1-